| 151 |
Candida IgM Ak |
A-858v4 |
| 152 |
Cannabidiol (quant.) |
F-1739v1 |
| 153 |
Cannabinoide i. Mekonium (qual.) |
F-1517v1 |
| 154 |
Cannabinoide im Urin (THC- COOH) |
A-950v2 |
| 155 |
Cannabinoide (qual.) |
F-1450v1 |
| 156 |
Cannabis im Urin (DRI), semiquantitativ |
A-403v3 |
| 157 |
Carbamazepin |
A-231v3 |
| 158 |
Carbapenemaseabklärung |
F-1351v1 |
| 159 |
Carboanhydrase II IgG AK |
F-1524v1 |
| 160 |
Carcinoembryonales Ag (CEA) |
F-1461v1 |
| 161 |
Carcinoembryonales Antigen (CEA) |
A-600v3 |
| 162 |
Cardiolipin IgG |
A-703v4 |
| 163 |
Cardiolipin IgM |
A-1062v3 |
| 164 |
Cariprazin |
F-1411v1 |
| 165 |
CASPR2 IgG Ak |
F-1313v1 |
| 166 |
CCP |
A-368v3 |
| 167 |
CDT |
A-779v4 |
| 168 |
Cefepim |
A-1615v1 |
| 169 |
Cefepim |
A-970v3 |
| 170 |
Ceftazidim |
A-971v3 |
| 171 |
Chlamydia pneumoniae IgA Ak |
A-1212v2 |
| 172 |
Chlamydia pneumoniae IgG Ak |
A-1211v2 |
| 173 |
Chlamydia trachomatis IgA Ak |
A-1210v2 |
| 174 |
Chlamydia trachomatis IgG Ak |
A-1209v2 |
| 175 |
Chlamydien-PCR CT/NG/MG/TV Assay |
A-588v3 |
| 176 |
Chlamydophila psittaci IgA Ak |
F-1677v1 |
| 177 |
Chlamydophila psittaci IgG Ak |
F-1678v1 |
| 178 |
Chlorid im Serum |
A-333v4 |
| 179 |
Chlorid im Urin |
A-342v4 |
| 180 |
Chlorpropamid |
F-1515v1 |
| 181 |
Cholesterin |
A-285v4 |
| 182 |
Cholinesterase (CHE) |
A-215v3 |
| 183 |
Chromogranin A |
F-1303v1 |
| 184 |
Citalopram; Escitalopram |
A-738v4 |
| 185 |
CK-Isoenzyme |
A-800v4 |
| 186 |
CK-MB |
A-216v4 |
| 187 |
Clindamycin |
F-1687v1 |
| 188 |
Clobazam |
F-1475v1 |
| 189 |
Clostridioides difficile: GDH und Toxin A/B |
A-1099v4 |
| 190 |
Clostridium botulinum-Toxin |
F-1353v1 |
| 191 |
Clozapin |
A-735v4 |
| 192 |
CMV DNA i. Sondermaterial |
F-1371v2 |
| 193 |
CMV DNA i. Stuhl |
F-1464v2 |
| 194 |
CMV IgG Ak |
A-343v5 |
| 195 |
CMV IgG Ak-Index |
A-391v4 |
| 196 |
CMV IgG Avidität (Vidas) |
F-1637v1 |
| 197 |
CMV IgM Ak |
A-836v4 |
| 198 |
Cocain i. Mekonium (qual.) |
F-1503v1 |
| 199 |
Cocain im Urin (CEDIA), semiquantitativ |
A-960v3 |
| 200 |
Cocain (qual.) |
F-1458v1 |